Calling CRM's Weakness: But Is Upside Ahead?
by Mike Paulenoff
January 10, 2021 • 4:17 PM EST
Back on Dec 2, after salesforce.com (CRM) reported strong earnings but price languished, Mike Paulenoff told MPTrader members:
"Weakness in reaction to the news has violated the prior significant near term pivot low at 228.66 (10/30), triggering the Bearish Scenario (Red line) that calls for a deeper correction that projects into the 220 area next, and if violated, to the 205 - 200 target zone."
In an update on the stock on Dec 16, Mike wrote: "Remarkably, in the two weeks since its post-earnings plunge from 266 to 215.63 -- largely a reaction to CRM's purchase of Slack Technologies for $27.7 billion -- this volatile, powerhouse of a name has languished beneath 230."
He added: "From my technical perspective, although CRM could have put in a successful retest of the low yesterday at 218.20, unless and until CRM claws its way above 230, my pattern work cannot rule out another bout of weakness into the 208 to 205 target zone. Last is 223.92."
This past week the stock got down to a double-low of 215.72 on Monday and 215.78 on Wednesday.
The very next morning, on Thursday, Mike wrote: "My pattern and momentum work argue that CRM is very close to the completion of its Sep-Jan corrective process (284.87 to 215.72 so far) and, therefore, is nearing the initiation of a new upleg."
He added: "Should CRM climb and sustain above 223-225, my nearest term work will trigger an initial buy signal that the correction was completed at the double low on 1/04 and 1/06 at 215.72/78."
On Friday CRM closed at 222.25, up 2% on the day, after trading at 219.22 early in the session. The fact that CRM reversed from a point of price vulnerability early in the session to a session-high close well into positive territory -- poised to challenge consequential near-term resistance at 223-225 that Mike had alerted members to the prior session -- is what MPTrader.com is all about: identifying actionable technical set-ups.
Will CRM open higher on Monday, pushing through initial resistance, finally begin participating in the November-January advance? Join Mike and mptrader members in our trading room for updates and discussion about CRM as well as many other stocks, indices, ETFs, cryptocurrencies, and precious metals.
During the afternoon session of February 15, this is what Mike Paulenoff posted to the MPTrader Discussion Room about the technical setup in the oil service company SLB (Schlumberger):"This name in the oil service sector exhibits a well-demarcated 4-year bullish channel with the SLB price structure upturning off of the lower boundary line in the vicinity of 47.00 (the 2/13/24 low) amid a glaring double non-confirmation of the weakness into the lower channel line.
On December 26, 2023, fellow MPTrader member FJB asked me the following question: Mike - do you feel comfortable giving some of your top sectors for next year if you have any? This was my response:In order of preference based on my technical setup work:1- XLV (Healthcare)2- XLB (Materials)3- XLE (Energy)4- XLI (Industrials)5- XLF (Financials)As of the close this past Friday, 3/15/24, YTD results showed XLV +6.58%, XLB +6.15%, XLI +7.06%, XLF +8.54%, and XLE (Energy) leading all sectors, at +9.27%.
On February 23, Mike Paulenoff posted the following timely commentary about the bond market to MPTrader members:"Benchmark 10-year YIELD and TLT (20+ Year T-bond ETF)-- I am getting initial, but very strong technical signals that the backup in 10-year YIELD from the late-March low at 3.78% to yesterday's (2/22/24) high at 4.35% is nearing exhaustion ahead of a rollover into another downleg within the larger downleg off of the October 2023 high at 5.00% (see my attached Daily Chart).
On October 27, 2023, Mike Paulenoff discussed his outlook for XBI (SPDR SP Biotech ETF) with our MPTrader members, writing:With the exception of a few months of recovery rally price action here and there, XBI remains in the grasp of a major bear phase off of its February 2021 peak at 174.79 into today's 17-month new low at 64.78. The $64,000 question is whether or not XBI is coming in for a successful test of its May-June 2022 lows at 61.78 and 62.
Nearly four months ago, on the morning of October 31, 2023, this is what I posted to our discussion room about NVDA (Nvidia Corp):NVDA pressed to a new 4-1/2 month low at 392.30 today, and ... the price structure is peering over the edge of a multi-month support plateau (396.50 to 407.64) that if sustained, will leave NVDA vulnerable to downside continuation toward filling the up-gap left behind on 5/25/23 from 305.40 to 366.35. So far, NVDA has bounced off of 392.30 and has just crossed above 400.